Fact Meets Function

Food-Derived Tripeptide-Copper Self-Healing Hydrogel for Infected Wound Healing.

Researchers developed a self-healing hydrogel containing a food-derived tripeptide (GHK) complexed with copper that was evaluated for infected wound healing properties in preclinical models. The hydrogel demonstrated antimicrobial activity against wound pathogens, promoted tissue repair processes, and maintained structural integrity through self-healing mechanisms. This study represents **animal model/in vitro evidence** of a potential wound treatment approach, with further clinical testing needed to establish safety and efficacy in human patients.

Food-Derived Tripeptide-Copper Self-Healing Hydrogel for Infected Wound Healing. Read Post »

β-Nicotinamide mononucleotide supplementation prolongs the lifespan of prematurely aged mice and protects colon function in ageing mice.

This animal model study investigated β-nicotinamide mononucleotide (NMN) supplementation in mice with premature aging and age-related decline. Researchers found that NMN supplementation extended lifespan in prematurely aged mice and improved colon function in aging mice, suggesting potential effects on age-related physiological decline. This is **animal model evidence** and does not directly translate to human outcomes without further clinical investigation.

β-Nicotinamide mononucleotide supplementation prolongs the lifespan of prematurely aged mice and protects colon function in ageing mice. Read Post »

A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment.

This preclinical study evaluated a nanoparticle delivery platform designed to promote mucosal healing and modulate immune responses in inflammatory bowel disease models. The research demonstrated that the nanoparticle formulation containing KPV (a tripeptide) enhanced intestinal barrier function and reduced inflammatory markers in laboratory and animal model systems. This represents early-stage evidence (animal model/in vitro) requiring further human clinical testing before any therapeutic application can be established.

A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment. Read Post »

A Synthetic ERR Agonist Alleviates Metabolic Syndrome.

Researchers investigated the effects of SLU-PP-332, a synthetic estrogen-related receptor (ERR) agonist, on metabolic syndrome in an animal model. The compound was found to alleviate metabolic syndrome symptoms, suggesting potential therapeutic applications for this drug target. This is animal model evidence and requires further human clinical investigation before applicability to patient care.

A Synthetic ERR Agonist Alleviates Metabolic Syndrome. Read Post »

PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced ColitiS.

Researchers developed a nanodrug delivery system that combines an anti-inflammatory peptide (KPV) with an immunosuppressant drug, designed to target PepT1 transporters in the intestine for treatment of colitis in a mouse model (Evidence level: Animal Model). In DSS-induced colitis models representing both acute and chronic disease, the targeted nanodrug demonstrated improved efficacy compared to free drug components, reducing inflammation and improving disease markers. This work represents a proof-of-concept for peptide-immunosuppressant co-assembly as a targeted delivery strategy, though translation to human clinical use remains to be determined.

PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced ColitiS. Read Post »

Intranasal GHK peptide enhances resilience to cognitive decline in aging mice.

Research Summary

Researchers administered the GHK peptide intranasally to aging mice and assessed its effects on cognitive function and resilience to decline. The study found that intranasal GHK peptide treatment was associated with enhanced cognitive resilience and reduced cognitive decline in the aging mouse model. This is an **animal model study** with potential relevance to understanding peptide-based approaches in aging, though findings require validation in human populations before clinical application.

Intranasal GHK peptide enhances resilience to cognitive decline in aging mice. Read Post »

“Drug-Carrier” Synergy Therapy for Amyloid-β Clearance and Inhibition of Tau Phosphorylation via Biomimetic Lipid Nanocomposite Assembly.

Researchers investigated a biomimetic lipid nanocomposite delivery system combining methylene blue (the active agent) with a carrier component designed to address two hallmarks of Alzheimer’s disease pathology: amyloid-β accumulation and tau phosphorylation (in vitro and animal model studies). The nanocomposite demonstrated enhanced clearance of amyloid-β and reduced tau phosphorylation compared to methylene blue alone, suggesting synergistic effects from the drug-carrier combination. **Evidence level: Preclinical (in vitro and animal model).**

“Drug-Carrier” Synergy Therapy for Amyloid-β Clearance and Inhibition of Tau Phosphorylation via Biomimetic Lipid Nanocomposite Assembly. Read Post »

Methylene blue and photobiomodulation recover cognitive impairment in hepatic encephalopathy through different effects on cytochrome c-oxidase.

Researchers investigated how methylene blue and photobiomodulation (light therapy) each improved cognitive function in an animal model of hepatic encephalopathy by examining their effects on cytochrome c-oxidase, a key enzyme in cellular energy production. Both treatments restored cognitive performance in affected animals, but through distinct mechanisms—methylene blue directly enhanced cytochrome c-oxidase activity while photobiomodulation worked through different pathways affecting the same enzyme. This animal model study provides mechanistic insight into how these interventions may address the mitochondrial dysfunction underlying cognitive impairment in hepatic encephalopathy.

Methylene blue and photobiomodulation recover cognitive impairment in hepatic encephalopathy through different effects on cytochrome c-oxidase. Read Post »

Hydrogels based on low-methoxyl amidated citrus pectin and flaxseed gum formulated with tripeptide glycyl-l-histidyl-l-lysine improve the healing of experimental cutting wounds in rats.

Researchers evaluated hydrogels made from low-methoxyl amidated citrus pectin and flaxseed gum combined with the tripeptide GHK (glycyl-L-histidyl-L-lysine) for wound healing in a rat cutting wound model. The hydrogel formulation demonstrated improved healing outcomes in the experimental wounds compared to control groups. This is **animal model evidence** with no direct human clinical applicability at this stage.

Hydrogels based on low-methoxyl amidated citrus pectin and flaxseed gum formulated with tripeptide glycyl-l-histidyl-l-lysine improve the healing of experimental cutting wounds in rats. Read Post »

[Anti-Aging Approach for Ocular Disorders: from Dry Eye to Retinitis Pigmentosa and Myopia].

This animal model study reviewed anti-aging approaches for treating various ocular disorders including dry eye disease, retinitis pigmentosa, and myopia, with investigation into compounds such as NMN (nicotinamide mononucleotide). The research examined how age-related cellular mechanisms contribute to these eye conditions and evaluated potential interventions targeting aging pathways. As an animal model study, these findings require further validation in human clinical trials before application to patient populations.

[Anti-Aging Approach for Ocular Disorders: from Dry Eye to Retinitis Pigmentosa and Myopia]. Read Post »

The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system.

This preclinical study (in vitro and animal model evidence) investigated how angiotensin IV-derived peptides, specifically dihexa, enhance cognitive function and synapse formation, finding that these effects depend on activation of the hepatocyte growth factor (HGF)/c-met signaling pathway. Researchers demonstrated that blocking the HGF/c-met system prevented the cognitive and synaptogenic benefits typically observed with these peptides in their experimental models. The findings suggest that the HGF/c-met pathway is a critical mechanism underlying the procognitive effects of angiotensin IV-derived peptides.

The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system. Read Post »

Effects of topical copper tripeptide complex on wound healing in an irradiated rat model.

This animal model study examined how a topical copper tripeptide complex (GHK-Cu) affected wound healing in rats that had been exposed to radiation. The research found that the copper tripeptide complex demonstrated beneficial effects on wound healing parameters in the irradiated rat model. This is an animal model study with limited direct applicability to human clinical practice.

Effects of topical copper tripeptide complex on wound healing in an irradiated rat model. Read Post »

Scroll to Top